Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate
Product Images NDC 0115-1331

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 0115-1331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Global Pharmaceuticals, Division Of Impax Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amphetamine 1)

A line graph depicting the mean plasma concentrations of dextroamphetamine and levoamphetamine over 24 hours. It compares two products, MAS-ER 20 mg once daily and ADDERALL 10 mg twice daily, showing plasma levels (ng/mL) on the Y-axis and time (hours) on the X-axis.*

FDA Label Image

Principal Display Panel (5 mg Bottle Label)

Label for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate extended-release capsules by Global Pharmaceuticals, Division of Impax Laboratories. The label indicates a 5 mg strength, 100 capsules per container, and includes dosage form and labeler information. It also shows storage instructions and cautions.*

FDA Label Image

Principal Display Panel (10 mg Bottle Label)

Label for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate extended-release capsules, containing 10 mg strength. The label indicates 100 capsules per package, Rx only, and includes storage instructions along with lot and expiration placeholders. Labeler is Global Pharmaceuticals, Division of Impax Laboratories Inc.*

FDA Label Image

Principal Display Panel (15 mg Bottle Label)

Label for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate extended-release capsules, 15 mg strength. The label indicates the product contains 100 capsules and is Rx only. It is distributed by Global Pharmaceuticals, Division of Impax Laboratories Inc. The label includes an NDC number, lot and expiration placeholders, storage instructions, and a barcode.*

FDA Label Image

Principal Display Panel (20 mg Bottle Label)

Label for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate extended-release capsules, 20 mg strength, by Global Pharmaceuticals, Division of Impax Laboratories Inc. The label indicates the product contains 100 capsules and includes storage instructions, a barcode, and space for lot and expiration dates.*

FDA Label Image

Principal Display Panel (25 mg Bottle Label)

Label for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate 25 mg extended-release capsules. The label shows the product name, strength, dosage form, and that it is Rx only. It includes the NDC number 0115-1332-01, lot and expiration date fields, and storage instructions. The label is from Global Pharmaceuticals, a division of Impax Laboratories Inc., and indicates a package of 100 capsules.*

FDA Label Image

Principal Display Panel (30 mg Bottle Label)

Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate extended-release capsules, 30 mg strength. The package size is 100 capsules. The label includes the NDC 0115-1333-01, indicates prescription use only, and lists Global Pharmaceuticals, Division of Impax Laboratories Inc. as the labeler. Additional storage and packaging information is present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.